Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Azanucleoside")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 532

  • Page / 22
Export

Selection :

  • and

Synthesis of 8-aza-2'-deoxyadenosine and related 7-amino-3H-1,2,3-triazolo[4,5-d]pyrimidine 2'-deoxyribofuranosides: stereoselective glycosylation via the nucleobase anionKAZIMIERCZUK, Z; BINDING, U; SEELA, F et al.Helvetica chimica acta. 1989, Vol 72, Num 7, pp 1527-1536, issn 0018-019X, 10 p.Article

Pharmacology of 5-Aza-2'-deoxycytidine (decitabine)MOMPARLER, Richard L.Seminars in hematology. 2005, Vol 42, Num 3, pp S9-S16, issn 0037-1963, SUP2Article

Decitabine dosing schedulesKANTARJIAN, Hagop M; ISSA, Jean-Pierre J.Seminars in hematology. 2005, Vol 42, Num 3, pp S17-S22, issn 0037-1963, SUP2Article

Issues regarding study design for initial clinical trials using decitabineDEBAUN, Michael R.Seminars in hematology. 2004, Vol 41, Num 4, pp 23-27, issn 0037-1963, 5 p., SUP6Conference Paper

Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulationVENTURELLI, Sascha; BERGER, Alexander; FULDA, Simone et al.Gut. 2011, Vol 60, Num 2, pp 156-165, issn 0017-5749, 10 p.Article

Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine)MOMPARLER, Richard L.Seminars in oncology. 2005, Vol 32, Num 5, pp 443-451, issn 0093-7754, 9 p.Article

Synthesis of 3'-deoxy-3'-difluoromethyl azanucleosides from trans-4-hydroxy-L-prolineQIU, Xiao-Long; QING, Feng-Ling.Journal of organic chemistry. 2005, Vol 70, Num 10, pp 3826-3837, issn 0022-3263, 12 p.Article

Decitabine in chronic leukemiasISSA, Jean-Pierre J; BYRD, John C.Seminars in hematology. 2005, Vol 42, Num 3, pp S43-S49, issn 0037-1963, SUP2Article

Decitabine in myelodysplastic syndromesSABA, Hussain I; WIJERMANS, Pierre W.Seminars in hematology. 2005, Vol 42, Num 3, pp S23-S31, issn 0037-1963, SUP2Article

Clinical development of decitabine as a prototype for an epigenetic drug programROSENFELD, Craig S.Seminars in oncology. 2005, Vol 32, Num 5, pp 465-472, issn 0093-7754, 8 p.Article

Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesisPASCALE, R; SIMILE, M. M; RUGGIU, M. E et al.Cancer letters. 1991, Vol 56, Num 3, pp 259-265, issn 0304-3835, 7 p.Article

DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical resultsDIGEL, Werner; LÜBBERT, Michael.Critical reviews in oncology/hematology. 2005, Vol 55, Num 1, pp 1-11, issn 1040-8428, 11 p.Article

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation settingSANCHEZ-ABARCA, Luis I; GUTIERREZ-COSIO, Silvia; FLORES, Teresa et al.Blood. 2010, Vol 115, Num 1, pp 107-121, issn 0006-4971, 15 p.Article

5 -Azacytidine -induced methyltransferase-DNA adducts block DNA replication in vivoKENNY KUO, H; GRIFFITH, Jack D; KREUZER, Kenneth N et al.Cancer research (Baltimore). 2007, Vol 67, Num 17, pp 8248-8254, issn 0008-5472, 7 p.Article

2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylationELLERHORST, J. A; FROST, P; ABBRUZZESE, J. L et al.British journal of cancer. 1993, Vol 67, Num 2, pp 209-215, issn 0007-0920Article

8-Aza derivatives of 3-deazapurine nucleosides. Synthesis and in vitro evaluation of antiviral and antitumor activityFRANCHETTI, P; MESSINI, L; CAPPELLACCI, L et al.Antiviral chemistry & chemotherapy. 1993, Vol 4, Num 6, pp 341-352, issn 0956-3202Article

Approval summary : Azacitidine for treatment of myelodysplastic syndrome subtypesKAMINSKAS, Edvardas; FARRELL, Ann; WANG, Yong-Cheng et al.Clinical cancer research. 2005, Vol 11, Num 10, pp 3604-3608, issn 1078-0432, 5 p.Article

Characterization of dna demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndromeMUND, Cora; HACKANSON, Björn; STRESEMANN, Carlo et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7086-7090, issn 0008-5472, 5 p.Article

Evaluation of a 7-day continuous intravenous infusion of decitabine: Inhibition of promoter-specific and global genomic DNA methylationSAMLOWSKI, Wolfram E; LEACHMAN, Sancy A; KARPF, Adam R et al.Journal of clinical oncology. 2005, Vol 23, Num 17, pp 3897-3905, issn 0732-183X, 9 p.Article

Decitabine in acute myeloid leukemiaLÜBBERT, Michael; MINDEN, Mark.Seminars in hematology. 2005, Vol 42, Num 3, pp S38-S42, issn 0037-1963, SUP2Article

Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineLAVELLE, Donald; VAITKUS, Kestis; COVEY, Joseph et al.Blood. 2012, Vol 119, Num 5, pp 1240-1247, issn 0006-4971, 8 p.Article

DNA methylation changes after 5-Aza-2'-deoxycytidine therapy in patients with leukemiaYANG, Allen S; DOSHI, Ketan D; KANTARJIAN, Hagop M et al.Cancer research (Baltimore). 2006, Vol 66, Num 10, pp 5495-5503, issn 0008-5472, 9 p.Article

Synthesis and in vitro anti-hepatitis B virus activity of six-membered azanucleoside analoguesDAN WANG; LI, Yu-Huan; WANG, Yu-Ping et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 1, pp 41-51, issn 0968-0896, 11 p.Article

Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structureGAWIN, Rafał; DE CLERCQ, Erik; NAESENS, Lieve et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 18, pp 8379-8389, issn 0968-0896, 11 p.Article

Kinetics and mechanism of the acid-catalysed hydrolysis of regioisomeric benzotriazole and 8-azaadenine nucleosidesKAPPI, R; KAZIMIERCZUK, Z; JARVINEN, P et al.Perkin transactions. 2. 1991, Num 5, pp 595-600, issn 0300-9580, 6 p.Article

  • Page / 22